Neurocrine Biosciences Posts Q3 Adjusted EPS of $3.29

UMH Properties Expects 2026 Normalized FFO of $0.99-$1.03 UMH Properties expects full-year 2026 normalized FFO of $0.99-$1.03, versus a FactSet estimate of $1. M impact | EARNINGS | Nov 02, 2026, 10:34 PM UTC

Innovative Industrial Properties Posts Q3 Adjusted FFO of $1.96 Q3 adjusted FFO was $1.96, versus the FactSet estimate of $1.71. M impact | EARNINGS | Nov 02, 2026, 10:33 PM UTC

5N Plus On Track to Reach High End of 2026 EBITDA Guidance 5N Plus said it is on track to achieve the high end of its full-year 2026 adjusted EBITDA guidance range. L impact | EARNINGS | Nov 02, 2026, 10:33 PM UTC

UMH Properties Reports Q3 Normalized FFO of $0.26 UMH Properties reported Q3 normalized FFO of $0.26, matching the FactSet estimate of $0.26. M impact | EARNINGS | Nov 02, 2026, 10:33 PM UTC

Toromont Reports Q3 Basic EPS of CAD 2.35 L impact | EARNINGS | Nov 02, 2026, 10:33 PM UTC

RioCan Q3 Core FFO per Unit Rises 5.1% RioCan said third-quarter core FFO per unit rose 5.1%, citing retail occupancy strength. M impact | EARNINGS | Nov 02, 2026, 10:32 PM UTC

Neurocrine Biosciences Posts Q3 Adjusted EPS of $3.29

Story updates

Related stories